Introduction
Polypeptide growth factors are critical in regulation of cellular activities such as proliferation, dierentiation, migration and cell survival and death. Many growth factors, such as the ®broblast growth factors (FGF) exert their eects by binding with high anity to cognate cell surface receptors with intrinsic, stimulatable tyrosine kinase activity. The FGF family encompasses, to date, about 20 members involved in a wide range of biological processes, such as embryonal development, angiogenesis and wound healing (Basilico and Moscatelli, 1992; Burgess and Maciag, 1989; Folkman and Klagsbrun, 1987) .
Fibroblast growth factor receptors (FGFRs) form a subfamily of receptor tyrosine kinases. Four structurally related members of this family have been characterized, FGFR-1 ± FGFR-4 Johnson and Williams, 1993) , that all have an extracellular ligand-binding part with two or three immunoglobulin-like loops, a single membrane spanning stretch and an intracellular part encompassing the kinase domain which is split in two parts by a 14 ± 17 amino acid residue stretch, denoted the kinase insert. FGF receptors are activated upon ligand binding and trans-phosphorylate each other in the FGF induced receptor-dimer. Seven tyrosine residues in the FGFR-1 intracellular domain have been shown to become phosphorylated upon ligand binding (Mohammadi et al., 1996; Peters et al., 1992) . Phosphorylated tyrosine residues, and surrounding amino acids, serve as binding sites for proteins with Src homology (SH)2 domains. In the FGFR-1, only Tyr766 have been identi®ed as a direct binding site for an SH2 containing protein; phospholipase C-g (PLC-g) (Mohammadi et al., 1992; Peters et al., 1992) . The role of PLC-g in FGFR-1 signaling is not clear, however, inhibition of PLC-g activation by mutation of the binding site in the FGFR-1 partly reduced the FGF-2 induced mitogenicity (Klint et al., 1995) , and PLC-g binding and activation by FGFR-1 has been implicated in regulation of Src kinase activity (Landgren et al., 1995) .
Another important signal transduction pathway downstream of FGFR-1 is the so called Ras pathway. The membrane anchored GTP-binding protein Ras is activated in FGFR-1 mediated signaling. We and others have described how FGFR-1 couples to activation of Ras via phosphorylation of two independent adaptor proteins, Shc and FRS2 (Klint et al., 1995; Kouhara et al., 1997) . Shc consists of a single SH2 domain, a collagen-homology domain and a phosphotyrosine-binding (PTB) domain (Pelicci et al., 1992) . The FRS2 adaptor is a major tyrosinephosphorylated protein in FGF-2 stimulated cells that contains a putative PTB domain and is associated with the membrane via a myristyl group (Kouhara et al., 1997) . Phosphorylation of these adaptors creates binding sites for the Grb2 adaptor in complex with the Ras activating, nucleotide exchange factor Sos. Activation of Ras is one of several prerequisites for activation of the downstream serine/threonine kinase Raf1. Full activation of Raf1 depends on its targeting to the membrane, mediated by binding to GTP-bound Ras, and phosphorylation, at least in part mediated by Src and protein kinase C (PKC) (Kolch et al., 1993; Stokoe and McCormick, 1997) . A cascade of kinases is activated downstream of Raf1; Raf1 phosphorylates and activates the dual speci®city kinase MAPK/ERK kinase (MEK1), which in turn stimulates the mitogenactivated protein (MAP) kinases ERK1 and -2 (Kosako et al., 1993; Moodie et al., 1993) . This linear Ras ± MAPK pathway is well established, however, an increasing number of reports describe that these kinases participate in a more complex cross-talk with other kinases and substrates (Pawson, 1995) .
Src family members are cytoplasmic tyrosine kinases that are anchored to the plasma membrane through an N-terminal myristyl group. The N-terminal region of Src contains a variable domain, an SH2 domain and an SH3 domain. The kinase domain is followed by a Cterminal regulatory domain. Src family kinases are involved in a broad range of cellular responses ranging from cell division and cytoskeletal rearrangments in ®broblasts, to dierentiation of neuronal PC12 cells (Kremer et al., 1991; Thomas et al., 1995; TwamleyStein et al., 1993) . Whether there is a direct association between Src and FGFR-1 or not, is a matter of discussion. The nonreceptor tyrosine kinase FAK contains a central kinase domain which is¯anked by N-and C-terminal domains lacking SH2 and SH3 domains. Several studies have shown direct binding of Src SH2 domain to the major autophosphorylation site of FAK (Schaller et al., 1994; Xing et al., 1994) . This interaction is thought to occur in subcellular compartments called focal adhesions, where the cell contacts and binds to the extracellular matrix. Focal adhesion complexes have been isolated and shown to contain Src and FAK as well as FGFR-1 (Plopper et al., 1995) .
Angiogenesis is a strictly regulated process, where new vessels are formed from pre-existing ones (Folkman, 1986) . In order to study the molecular mechanisms in endothelial cell dierentiation, we have established a capillary endothelial cell line from transgenic mice (IBEC; Immortomice Brain Endothelial Cells) that have the advantage of responding to FGF-2 stimulation with proliferation or dierentiation, dependent on the culture condition (Kanda et al., 1996) . Thus, exogenously added FGF-2 leads to IBEC dierentiation and the formation of lumen-containing tubes when cells are cultured between two layers of collagen gel. Using this cell line we compared FGFR-1 mediated signal transduction in proliferating and dierentiating endothelial cells. We found that the FGFR-1 utilizes dierent sets of receptor proximal adaptors at the onset of intracellular signal transduction in these two cellular responses. Furthermore, we present evidence that persistent MAPK activation is not absolutely crucial for tube-formation of IBEC, and suggest a role for Src family members in FGFR-1 mediated endothelial cell dierentiation.
Results
We have established an in vitro cell model to study growth factor-mediated signal transduction in endothelial cell dierentiation. A capillary endothelial cell line, denoted IBEC (Immortomice Brain Endothelial Cell), was isolated from brains of transgenic mice and shown to display a number of endothelial cell-speci®c markers (Kanda et al., 1996) . We showed that culturing IBEC on ®bronectin in the presence of FGF-2 resulted in a Figure 1 Proliferation or dierentiation of IBEC after FGF-2 stimulation. Cells were inoculated onto ®bronectin-coated dishes and cultured in the presence or absence of 5 ng/ml FGF-2. Cells cultured between two layers of collagen-gel were induced to dierentiate by addition of 5 ng/ml FGF-2 or left untreated for 18 h Figure 2 (a) Eect of Ras inhibitors on FGF-2 induced IBEC proliferation. IBEC were inoculated into wells of 24-well plates coated with ®bronectin and cultured at 338C. The cells were incubated in the presence or absence of 1 ng/ml FGF-2 and in the presence or absence of the Ras inhibitors manumycin or FTS, as indicated. After 3 days of culture the cells were detached and counted. (b) Eect of Ras inhibitors on FGF-2 induced IBEC dierentiation. IBEC were cultured between two layers of collagengel in the presence or absence of 5 ng/ml FGF-2, and in the presence or absence of the Ras inhibitors manumycin or FTS, or vehicle alone as indicated. Pictures were taken 18 h after inoculation Figure 3 Dierential association of FRS2 and Shc to Grb2 in proliferation and dierentiation. IBEC were inoculated onto ®bronectin-or collagen-gel-coated dishes and allowed to adhere for 3 h before addition of FGF-2. Cells were left untreated (7) or stimulated with 5 ng/ml FGF-2 for indicated time points and cell lysates were collected. (a) Sepharose-immobilized GST ± Grb2 SH2 or p13suc-agarose was added to the lysates and precipitated material was separated by SDS ± PAGE and immunoblotted with P-Tyr antibody. (b) Sepharose-immobilized GST ± Grb2 SH2 was added to the lysates and precipitated material was separated by SDS ± PAGE and immunoblotted with Shc antiserum. Prec, precipitation; Blot, immunoblotting Figure 4 (a) Sustained MAPK activity in proliferation and dierentiation. IBEC were inoculated onto ®bonectin-(circles) or collagen-gel-(squares) coated dishes and were either left unstimulated and lysed at indicated time points (open symbols) or allowed to adhere for 3 h before addition of 5 ng/ml FGF-2 and thereafter lysed at indicated time points (®lled symbols). ERK2 was immunoprecipitated from the cell lysates and the precipitates were subjected to kinase assay in the presence of 5 mCi [g-32 P]ATP and 10 mg myelin basic protein. Kinase reactions were performed for 15 min at 308C and samples were separated by SDS ± PAGE and analysed using a Bio-Imager. A representative result of MBP phosphorylation by ERK2 is plotted as fold activation above unstimulated cells in suspension. (b) FGF-2, but not EGF or PDGF-BB, results in sustained MAPK activity in IBEC cultured on collagen. IBEC were inoculated onto collagen-gel and allowed to adhere for 3 h. Cells were then left untreated (7) or stimulated with 5 ng/ml FGF-2, EGF or PDGF ± BB for indicated time points, and subsequent ERK2 precipitates were subjected to kinase assay as described above. A representative resulting autoradiogram is shown. MBP, myelin basic protein FGFR-1 mediated endothelial cell differentiation P Klint et al proliferative response. On the other hand, FGF-2 stimulation of IBEC cultured between two layers of collagen gels led to dierentiation and the formation of tube-like structures (Figure 1 ) in the absence of DNA synthesis (Kanda et al., 1999) . Cells that were seeded between two layers of collagen and denied FGF-2 did not form tubes and underwent apoptosis.
Involvement of Ras in proliferation and dierentiation of IBE cells
Since dierentiation of IBEC was exclusively dependent on the presence of FGF-2, we were interested in characterizing signal transduction from FGFR-1 in cells cultured on ®bronectin or collagen. To determine if FGFR-1 signaling in cells cultured on ®bronectin or collagen was dependent on monomeric GTP-binding proteins, we utilized two dierent inhibitors; the farnesylation inhibitor manumycin (Hara et al., 1993) and the Ras-dislodging antagonist FTS (Haklai et al., 1998) . These inhibitors are known to aect Ras function since membrane association is a prerequisite for Ras activity (Howe et al., 1992; Leevers and Marshall, 1992) ; the eect of manumycin on geranylgeranylated Ras-like proteins such as Rac and RhoA and C remain to be determined (Cox and Der, 1997) . Changes in cell numbers was monitored in a proliferation assay and treatment of IBEC with either inhibitor reduced the capacity of the cells to proliferate in response to FGF-2 ( Figure 2a ). It was also evident that Ras proteins are engaged in dierentiating cells since both manumycin and FTS treatment of FGF-2 stimulated IBEC cultured between collagen gels compromised tube formation, but did not induce cell death (Figure 2b ). Ras inhibition in cells cultured between collagen gels was accompanied by a 50% reduction in FGF-2 induced MAPK activity, as compared to cells that were treated with FGF-2 only (data not shown). From these data we infer that functional Ras is important in both FGF-2 induced endothelial cell proliferation and dierentiation.
Dierential association of FRS2 and Shc to Grb2 in proliferation and dierentiation
We have previously shown that two major routes are utilized by the FGFR-1 to activate Ras, involving recruitment of the Grb2 ± Sos complex to either of the two adaptor molecules Shc and FRS2 (Klint et al., 1995) . In order to determine how the FGFR-1 couples to Ras in the two culture conditions described above we examined coprecipitation of FRS2 or Shc with Grb2. A time course experiment was performed where cell lysates were collected after indicated time points of FGF-2 stimulation and allowed to react with an immobilized GST ± Grb2 SH2 domain fusion protein, followed by SDS ± PAGE and immunoblotting with phosphotyrosine antibodies. When IBEC were cultured on ®bronectin, FRS2 became rapidly tyrosine phosphorylated upon FGF-2 addition and associated with the Grb2 SH2 domain (Figure 3, upper panel) . A maximum level of phosphorylation was reached at 1 h which remained sustained. In contrast, when cells were cultured on collagen, FGF-2 failed to induce tyrosine phosphorylation of FRS2 and its association to Grb2, indicating that tyrosine phosphorylation of the FRS2 adaptor is not a prerequisite for dierentiation of IBEC. The p13suc protein has been shown to bind to FRS2 independent of phosphorylated tyrosine residues (Kouhara et al., 1997) . Precipitation using p13suc
Figure 5 (a) PD98059 attenuates FGF-2 induced ERK2 activity in IBEC cultured on collagen. IBEC were inoculated onto collagen-gel and allowed to attach to the substratum for 3 h (2-D culture), and the MEK inhibitor PD98059 was present the last hour before FGF-2 addition. Cells were left untreated or stimulated with 5 ng/ml FGF-2 for dierent time points and lysed. After immunoprecipitation of ERK2, the precipitates were subjected to kinase assay in the presence of 5 mCi [g-32 P]ATP and 10 mg myelin basic protein. Kinase reactions were performed for 15 min at 308C, samples were separated by SDS ± PAGE and analysed using a Bio-Imager. A representative result of MBP phosphorylation by ERK2 is plotted as fold activation above unstimulated cells in suspension. Untreated cells (&), FGF-2 stimulated cells in the absence (&) or presence (&) of 30 mM PD98059. (b) PD98059 attenuates FGF-2 induced ERK2 activity in IBEC cultured between two layers of collagen. IBEC were allowed to attach to the ®rst layer of collagen gel for 3 h before addition of a second collagen gel layer (3-D culture). Medium with or without the MEK inhibitor PD98059 was added 1 h before addition of FGF-2. At indicated time points medium and the top collagen layer was removed and the cells were lysed. Immunoprecipitation of ERK2 and kinase reaction was performed as described above. (c) PD98059 attenuates FGF-2 induced IBEC proliferation. IBEC were inoculated into wells of 24-well plates coated with ®bronectin and cultured at 338C. The cells were incubated in the presence or absence of 1 ng/ml FGF-2 and in the presence or absence of the MEK inhibitor PD98059 at two dierent concentrations, as indicated. After 3 days of culture the cells were detached and counted coupled to agarose followed by immunoblotting with phosphotyrosine antibodies, also showed sustained tyrosine phosphorylation of FRS2 in FGF-2 stimulated cells cultured on ®bronectin but not in cells cultured on collagen (Figure 3a , lower panel). The GST ± Grb2 SH2 pull-down allowed enrichment of heavily phosphorylated FRS2 after 1 h of stimulation, whereas when using p13suc-agarose, tyrosine phosphorylated FRS2 was detected already at 10 min of stimulation. This could possibly be due to tight complex formation between FRS2 and endogenous Grb2 at the early time points, alternatively, the tyrosine phosphorylated FRS2 protein detected through p13suc-agarose binding, could be involved in coupling to downstream signal transduction pathways other than Grb2 ± Sos. Thus, although we could not control immunoblot against the FRS2 protein due to lack of suitable reagents, we could demonstrate using both tyrosine phosphorylation-dependent and -independent precipitation techniques, that FRS2 is not tyrosine phosphorylated in FGF-2 treated, differentiating IBEC. On the other hand, FGF-2 stimulation promoted association of Shc to the Grb2 SH2 domain in dierentiating IBEC, while in ®bronectin cultured cells, lower levels of tyrosine phosphorylated Shc bound to Grb2 SH2 independent of FGF-2 addition (Figure 3b ). Similar levels of Shc proteins were extracted from cells in the two culture conditions (data not shown). Thus, the interaction between Shc and Grb2 was even more prominent when cells were grown on collagen than on ®bronectin, which is in agreement with data showing that adaptor molecules compete for a limited pool of Grb2 (Yamauchi and Pessin, 1994) . In conclusion, in proliferating IBEC the FGFR-1 activates Ras via two adaptor molecules, FRS2 and Shc, while in dierentiating cells the FRS2 adaptor is not engaged and Ras is activated by means of Shc recruitment.
Sustained MAPK activity in proliferation and dierentiation of IBE cells
We were interested in the downstrem eects of these signaling dierences at the receptor level and therefore examined the kinetics of MAPK activity in IBEC cultured on ®bronectin or collagen. In a time course setting the level of MAPK activation was determined in an in vitro kinase experiment where myelin basic protein (MBP) was used as an exogenous substrate. When inoculating suspended cells onto ®bronectin without addition of FGF-2 we observed an immediate and transient activation of MAPK (Figure 4a ), presumably due to integrin signaling (Schlaepfer et al., 1994) . This kinase activity returned to basal levels at 40 ± 60 min after inoculation. In cells seeded on collagen, FGF-2 independent activation of MAPK was not detected. Addition of FGF-2 to cells attached to ®bronectin led to an 80-fold increase in MAPK activity at 10 min of stimulation and later, a sustained high level of kinase activity that stabilized at a 40-fold level of activation above that in unstimulated cells kept in suspension (Figure 4a ). Sustained FGF-2 dependent MAPK activity was observed also in collagen cultured IBEC, although the level of activity was lower and stabilized at an increment of about 20-fold over basal. Thus, we conclude that MAPK activity is sustained Figure 6 Eect of MEK, PKC and Src inhibitors on IBEC dierentiation. IBEC were cultured between two layers of collagen-gel in the presence or absence of 5 ng/ml FGF-2, and in the presence or absence of indicated inhibitors or vehicle. PD98059, MEK inhibitor; GF109203X, PKC family inhibitor; PP1, Src family inhibitor. Pictures were taken 18 h after inoculation Figure 7 Raf1 is needed for IBEC dierentiation. IBEC were inoculated onto ®bronectin-or collagen-gel-coated dishes and allowed to adhere for 3 h before addition of 100 ng/ml FGF-2. Cell lysates were collected at indicated time points and immunoprecipitation was performed with Raf1 antiserum. Precipitates were subject to kinase assay in the presence of 5 mCi [g-32 P]ATP and 0.4 mg kinase-inactive MEK for 15 min at 308C. Samples were separated by SDS ± PAGE and the gel was analysed using a Bio-Imager. A representative result of kinase inactive MEK phosphorylation is plotted as fold induction above unstimulated cells FGFR-1 mediated endothelial cell differentiation P Klint et al upon FGF-2 stimulation both in proliferating and in dierentiating, tube forming, IBEC. We have shown previously that IBEC express endogenous receptors for EGF and PDGF ± BB, although these growth factors fail to induce dierentiation or cell survival (Kanda et al., 1996) . We tested the ability of these ligands to activate MAPK in cells cultured on collagen. As evident from the representative autoradiogram shown in Figure 4b , both EGF and PDGF ± BB stimulation resulted in a rapid activation of MAPK activity, as did FGF-2. However, only FGF-2 was capable of mediating sustained MAPK activity.
Activation of MAPK is not crucial for dierentiation of IBEC
In order to study the importance of MAPK in proliferating and dierentiating IBEC, cells were cultured in the presence or absence of the MEKspeci®c inhibitor PD98059. The cells, cultured on collagen, were preincubated with 30 mM inhibitor for 1 h before addition of FGF-2. FGF-2 induced MAPK activation was close to completely blocked by treatment with the inhibitor and the inhibition persisted throughout the assay (Figure 5a ). The same pattern of sustained MAPK activity, and the inhibitory eect of PD98059, was observed in cells cultured between two collagen layers (3-D culture; Figure 5b ). It was evident that FGF-2 induced proliferation was inhibited by treatment of the cells with the MEK inhibitor ( Figure 5c ). We next examined the eect of MAPK inhibition in differentiation of IBEC. As in the previous experiment, 30 mM of the MEK inhibitor was added to the cells 1 h prior to FGF-2 stimulation. As expected, unstimulated cells did not form any dierentiated structures, and even died in this prolonged culture condition. However, IBEC that were stimulated with FGF-2 fused and dierentiated into tube-like structures, a process that was unaected by the presence of the MEK-inhibitor ( Figure 6 ). Similar results were observed when adding doses of inhibitor up to 100 mM (data not shown). Thus, it was evident that MEK and MAPK activity are not required for FGF-2 induced IBEC dierentiation.
We went on to assess the contribution of Raf1 kinase activity in the process of dierentiation. The level of Raf1 activation was measured in an in vitro kinase assay where kinase-inactive MEK protein was used as a substrate. The Raf1 kinase was activated by FGF-2 stimulation in both culture conditions, although to dierent maximal levels ( Figure 7) . We are currently testing the role of Raf-1 in tubular morphogenesis by overexpression of dominant negative and constitutively active Raf1.
Src, but not PKC, is required for dierentiation of IBE cells
A number of signal transduction proteins have been shown to contribute to activation of components in the Ras pathway, i.e. the PKC family of serine/threonine kinases and the Src family kinases. Activation of FGFR-1 leads to phosphorylation and activation of phospholipase C-g (PLC-g), thereby generating inositol trisphosphate and diacylglycerol (DAG); DAG is the physiological activator of PKC. We ®rst determined whether FGFR-1 phosphorylates and thereby activates PLC-g in dierentiating cells. PLC-g was immunoprecipitated from cells grown on ®bronectin or cultured on collagen and the subsequent ®lter was immunoblotted with antibodies directed against phosphotyrosine. FGF-2 stimulation of IBEC resulted in tyrosine phosphorylation of PLC-g in dierentiating, collagen cultured cells as well as in proliferating, ®bronectin cultured cells (Figure 8 ). FGF-2 could thus potentially activate PKC in dierentiating IBEC and we therefore examined the eect of PKC inhibition on tube formation. GF109203X is a bisindolylmaleimide that has been shown to inhibit the classical PKC isoforms (Toullec et al., 1991) . Treatment of IBEC with 2.4 mM GF109203X did not aect tube formation, as seen in Figure 6 . Thus, the classical PKC isoforms appear not to be involved in dierentiation of the endothelial cells.
Src auto-kinase activity in proliferating and differentiating IBEC was studied in an in vitro kinase assay. Src protein was immunoprecipitated and kinase reactions were performed in the presence of [g-32 P]ATP. As shown in Figure 9a , a relatively high basal Src kinase activity was present in ®bronectin- Figure 8 PLC-g tyrosine phosphorylation in FGF-2 stimulated IBEC. IBEC were inoculated onto ®bronectin-or collagen-gelcoated dishes and allowed to adhere for 3 h. Cells were left untreated (7) or stimulated (+) with 100 ng/ml FGF-2 for 10 min before lysis. PLC-g was immunoprecipitated and the precipitates were subjected to SDS ± PAGE and immunoblotting with P-Tyr antibody or PLCg antiserum, respectively. FN, ®bronectin; coll., collagen; Ip, immunoprecipitation; Ib, immunoblotting FGFR-1 mediated endothelial cell differentiation P Klint et al cultured IBEC; treatment with FGF-2 did not further aect this activity level. The basal level of Src kinase activity was higher in the collagen cultured cells, and treatment with FGF-2 induced a small additional increase in Src kinase activity, as seen in Figure 9a . To further examine the role of Src in IBEC dierentiation, tube formation in collagen gels was performed in the presence or absence of the Src family inhibitor PP1 (Hanke et al., 1996) . PP1, or vehicle alone, was administred to the cells 1 h prior to FGF-2 addition. Under this condition, FGF-2 failed to induce fusion of cells and tube formation was completely blocked (Figure 6 ). Inhibition of Src family kinases by PP1 treatment (Figure 9c ) did not aect FGF-2 induced MAPK activity as shown in an in vitro kinase assay using MBP as a substrate (Figure 9b ). These data indicate an important role for Src family kinases in FGF-2 induced IBEC dierentiation. To further clarify the signal transduction pathway downstream of Src, we analysed the potential interaction between Src and FAK, which when activated is known to present a binding site for Src. FAK protein was immunoprecipitated from untreated and FGF-2 treated IBEC cultured on ®bronectin or collagen (Figure 9d , top panel). An FGF-independent low level FAK-Src association was detected in the ®bronectin cultured cells. In the collagen gel cultured cells, FGF-2 induced an elevated complex-formation between the two signaling molecules. The complex-formation was not dependent on high levels of tyrosine phosphorylated FAK. On the contrary, considerably higher levels of tyrosine phosphorylated FAK was detected in the ®bronectin cultured IBEC (Figure 9c , middle panel). Similar levels of FAK proteins was recovered from the two culture conditions (Figure 9d, lower panel) . These data indicate that Src family kinases could have a role in endothelial cell dierentiation and that downstream signal transduction via FAK is important in differentiation but not in proliferation of IBE cells.
Discussion
In this report, we show that FGF-2 stimulated murine brain endothelial cells contain elevated levels of MAPK activity during several hours after onset of stimulation. The sustained MAP kinase activity appeared both during proliferation and dierentiation, i.e. tube formation, of IBEC. Treatment of the cells with the MEK inhibitor PD98059 suppressed MAPK activity, which abrogated the proliferative response to FGF-2. Dierentiation of the IBEC, measured as tube formation in collagen gels was not aected by the PD98059 treatment. FGF-2 treated endothelial cells on collagen gels contained elevated levels of active Src and an inhibitor of Src kinase family members, PP1, interfered with tube formation. We therefore conclude that sustained MAP kinase activity is not a strict requirement for dierentiation, whereas Src kinase Figure 9 (a) Elevated Src kinase activity in FGF-2 treated collagen cultured IBEC. IBEC were inoculated onto ®bronectin-(circles) or collagen-gel-(squares) coated dishes and allowed to adhere for 3 h. Cells were left untreated (open symbols) or stimulated (®lled symbols) with 5 ng/ml FGF-2 for indicated time points, lysed and Src antiserum was added. Immunoprecipitates were subjected to kinase assay in the presence of 5 mCi [g-32 P]ATP for 15 min at 308C. Samples were separated by SDS ± PAGE and Src autophosphorylation analysed using a Bio-Imager, plot shows results from a representative experiment. (b) Inhibition of Src kinase does not aect ERK2 activity. IBEC were inoculated onto collagen-gel-coated dishes and allowed to attach for 3 h, and the Src family inhibitor PP1 was added 1 h before addition of FGF-2. Three hours after inoculation the cells were left untreated (0) or stimulated for indicated time points with 5 ng/ml FGF-2 and thereafter lysed. ERK2 antiserum was added and immunoprecipitates were subjected to kinase assay in the presence of 5 mCi [g- FGFR-1 mediated endothelial cell differentiation P Klint et al activity appears to be required for dierentiation in vitro of the endothelial cells. Activation, and in particular sustained activation, of MAPK has been correlated with a wide range of cellular responses, dependent on the cell type and the balance between dierent intracellular signals (Marshall, 1995) . For example, it has been shown that overexpression of the epidermal growth factor receptor in the phaeochromocytoma cell line PC12 results in a sustained MAPK activity that correlates with neuronal dierentiation (Traverse et al., 1994) . According to other reports where PC12 cells have been transfected with mutated PDGFR-b, sustained MAPK activity is not sucient for PC12 dierentiation and other signaling inputs are required (Vaillancourt et al., 1995) . Moreover, Pouyssegur and co-workers describe a critical role for persistent MAPK activation in proliferating lung ®broblasts (Meloche et al., 1992) . It is clear that a sustained level of MAPK activity is found in cells undergoing dramatically dierent processes. In this work, we show that MAPK activity is persistent in both proliferating and dierentiating IBEC, in the latter case analysed in both 2-D and 3-D collagen gel cultures, and thus not an exclusive event for either response. It is, however, possible that persistent MAPK activity could be necessary for survival of IBEC. In line with this is a recent study showing the necessity of sustained FGF-2 induced MAPK activity in a 48 h chorioallantoic membrane angiogenesis assay (Eliceiri et al., 1998) .
Adaptor proteins, lacking intrinsic enzymatic activity, are utilized by growth factor receptors for coupling to intracellular signaling cascades (Pawson, 1995) . Our ®nding that the FGFR-1 adaptor protein FRS2 is tyrosine phosphorylated upon FGF-2 stimulation in proliferating but not in dierentiating IBEC points to a novel regulatory mechanism in intracellular growth factor receptor signal transduction. As the FRS2 protein is a major FGFR-1 substrate, blocking its tyrosine phosphorylation should be critical for the output signal from the activated receptor. The persistent tyrosine phosphorylation of FRS2 in proliferating endothelial cells after FGF-2 stimulation was paralleled by a strong and sustained MAPK activation. It is conceivable that FRS2 serves as a potent amplifyer of receptor-induced activation of the Ras/MAPK pathway, as FRS2 contains four potential Grb2 binding sites. In dierentiating cells, where FRS2 fails to present binding sites for Grb2, the level of the sustained MAPK activity is lower. The mechanism of FRS2 regulation and its consequences for FGFR-1 signaling is a subject for further investigation. At this point we have not been able to strictly exclude that FRS2 protein levels are reduced in cells cultured on collagen, due to lack of reagents. However, we have analysed a number of other signal transduction molecules, such as FAK, Shc, ERK2 and Src which are recovered to similar extents independent of culture condition and stimulation (Figure 9d , lower panel and data not shown). Using PC12 cells, Kouhara et al. (1997) have inferred a role for FRS2 in dierentiation, i.e., neurite outgrowth, by overexpression of FRS2. Similar analysis in endothelial cells will show whether the function of FRS2 in dierentiation is cell speci®c.
Grb2 couples to Shc after FGF-2 treatment in proliferating as well as in dierentiating IBEC.
Notably, this complex exists already in unstimulated, ®bronectin-cultured cells which could be due to integrin-induced Shc phosphorylation (Figure 3 ; Schlaepfer et al., 1998) . However, in cells cultured on collagen the Grb2 ± Shc complex forms only after FGF-2 treatment and a larger pool of tyrosinephosphorylated, Grb2 associated, Shc is found in these cells than in cells cultured on ®bronectin. We and others have shown Shc to be an adaptor molecule for coupling of FGFR-1 to activation of Ras, but Gotoh et al. (1996) have described a role for Shc in signaling to c-myc gene expression and cell survival. The exact role for the receptor-proximal adaptors FRS2 and Shc in FGFR-1 signaling to dierentiation, survival and/or proliferation remains to be de®ned, which is of particular interest in relation to our demonstration of a dierential usage of these adaptors in dierentiation and proliferation.
In accordance with several studies in other cell systems (Haklai et al., 1998; Kim et al., 1997; Nagase et al., 1996) , treatment of the IBEC with Rasinhibitors inhibited FGF-2 induced cell proliferation. Our data suggest an obligatory signaling cascade to IBEC proliferation that starts with FGFR-1 activation, phosphorylation of the adaptor proteins Shc and FRS2 and subsequent activation of Ras followed by the linear Raf1/MEK/MAPK pathway. Also in the process of IBEC dierentiation, Ras is crucial as the Ras-inhibitors FTS and manumycin severely hampered tube formation. Since we could show that sustained MEK and MAPK activation was not critical for FGF-2 to induce IBEC dierentiation, signaling must branch o at at the level of Ras/Raf1. In agreement with this ®nding, a previous report studying a rat hippocampal cell line showed MEK/MAPK not to be sucient nor necessary to induce FGF-2 dependent dierentiation, but demonstrated the need for Ras in dierentiation in the hippocampal cells (Kuo et al., 1997) .
A clear inhibition of FGF-2 induced tube formation was observed when treating cells with the Src family inhibitor PP1. PP1 is a pyrazolopyrimidine which has been shown to inhibit the Src kinase family members Lck, FynT, Hck and Src (Hanke et al., 1996) . Src activity does not appear to be critical for FGF-2 stimulated cell survival, however, since endothelial cells treated with the Src family inhibitor were not adversely aected and formed aggregates, which appear prior to formation and elongation of tubes (Kanda et al., 1999) . The level of kinase active Src was higher in the collagen cultured cells than in the ®bronectin cultures, and FGF-2 had only a modest stimulatory eect on Src activity. It is thus possible that integrin activation contributes to modulation of Src signaling, in FGF-2 induced tube formation. Fibronectin induced activation of FAK and subsequent binding of Src to phosphorylated Tyr397 in FAK is a well established integrinmediated signaling event (Schaller et al., 1994; Xing et al., 1994) . Since Src activity is indispensable for IBEC dierentiation, it is interesting to note that FGF-2 has a potentiating eect on Src ± FAK complex-formation in the collagen-cultured IBEC, which occurs in spite of the modest level of tyrosine phosphorylated FAK in these cells. The level of associated Src ± FAK was considerably lower in the ®bronectin cultured cells, although these cells contained high levels of tyrosine FGFR-1 mediated endothelial cell differentiation P Klint et al phosphorylated FAK. A conceivable explanation for this ®nding is that Src and FAK are dierentially compartmentalized in the two culture conditions. Src activity initiates a plethora of signaling events, which have been implicated in proliferation, and in differentiation (see Figure 6 and Kuo et al., 1997) . It is not clear how dierent signal transduction pathways induced by Src contribute to the dierent cellular responses; our data indicate that FGFR-1 and integrin signaling converge on the level of Src to direct EC dierentiation.
A better understanding of endothelial cell responses to angiogenic factors such as FGF-2 is critical for development of therapeutical strategies in clinical settings e.g. wound healing and tumor growth. Our study contributes to this by dissecting the FGFR-1 mediated eects on endothelial cell proliferation and dierentiation.
Materials and methods

Cell culture
Murine brain capillary endothelial cells (IBEC) isolated from H-2Kb-tsA58 transgenic mice (Immortomice) were grown routinely on ®bronectin-and gelatin-coated dishes in Ham's F12 medium supplemented with 20% heat-inactivated fetal bovine serum (FBS; Sigma), 5 mg/ml bovine pancreas insulin (Sigma), 10 ng/ml mouse epidermal growth factor (Pepro Tech EC Ltd.), 20 U/ml mouse interferon g (Genzyme) and 75 mg/ml endothelial cell growth supplement (Sigma) at 338C as described previously (Kanda et al., 1996) .
Cell proliferation assay
IBEC in Ham's F12 medium containing 5% FBS were inoculated at a density of 1.5610 4 cells/cm 2 into wells of 24-well plates coated with human plasma ®bronectin and cultured at 338C. On the next day, medium was changed to Ham's F12 medium containing 2% FBS with either vehicle (DMSO) or inhibitor (Ras inhibitors manumycin (a kind gift of Dr Mitsunobu Hara, Tokyo Research Laboratory, Kyowa Hakko Kogyo Co. Ltd, Tokyo, Japan; ®nal concentration 1 mM) (Hara et al., 1993) or S-trans, trans-farnesylthiosalicylic acid (FTS; 50 mM ®nal concentration) (Haklai et al., 1998) . Twenty minutes later, 1 ng/ml FGF-2 was added as indicated and the culture was continued for 3 days. Cells were detached by trypsinization and the cell number was counted using a hemacytometer.
Tube formation assay
Tube formation assay between two layers of collagen gel was performed as described previously (Kanda et al., 1996) . Brie¯y, a mixture of 106F12 medium (Flow Laboratories, UK), type I collagen (Vitrogen 100; Collagen Corporation, Fremont, CA, USA) and 0.1 M NaOH (1 : 8 : 1) was added to wells of a 12-well dish and allowed to gelify for 1 h at 378C. IBEC were resuspended in F12 medium containing 0.25% bovine serum albumin (BSA, fatty acid free; Sigma), inoculated onto the collagen gel at a density of 1610 5 cells/cm 2 and cultured for 1 h at 338C in the absence or presence of inhibitors (Src family inhibitor PP1; Calbiochem; ®nal concentration 1 mM), MEK inhibitor PD98059 (BIO-MOL Research Laboratories, Inc; ®nal concentration 30 mM), PKC inhibitor GF109203X (Calbiochem; ®nal concentration 2.4 mM), the Ras inhibitor manumycin (®nal concentration 1 mM), and the Ras inhibitor FTS (®nal concentration 50 mM) before addition of 5 ng/ml FGF-2 (FarmItalia Carlo Erba, Milano, Italy). Two hours after addition of FGF-2, the medium was aspirated, new collagen mixture was added and allowed to solidify (3-D culture). After gelation, F12 medium containing 0.25% BSA with indicated supplements was added and culture continued at 338C over night. Tube-formation of IBE cells in response to FGF-2 could also be detected on 2-D cultures, i.e. after seeding cells on a single layer of collagen, however tubes were shorter and less well organized (data not shown).
Preparation of cells grown on ®bronectin-or collagen-gel-coated dishes
Culture dishes were coated for 1 h at 378C with either Ham's F12 medium containing 20 mg/ml human ®bronectin (Sigma) or collagen gel solution as indicated above. Cells were serumand supplement-starved in Ham's F12 medium containing 1% heat-inactivated FBS for 18 h before trypsinization and centrifugation. After resuspension in F12 medium containing 0.25% BSA the cells were inoculated onto ®bronectin-coated or collagen-gel-coated dishes. Cells were allowed to attach to the substratum for 3 h before addition of ligand. Cells were then incubated with or without ligand for indicated time points. Alternatively, a second layer of collagen was added (3-D culture) to cells seeded on collagen, before addition of medium with or without inhibitor. Ligand was added 1 h later and at indicated time points the upper collagen layer was removed and cells were washed with ice-cold phosphate buered saline and lysed.
Src kinase assay
IBEC were grown on ®bronectin or collagen as described above in wells of 6-well dishes for indicated time points with or without 5 ng/ml FGF-2. The cells were washed with icecold phosphate-buered saline (PBS) containing 100 mM Na 3 VO 4 and 0.5 ml Nonidet P-40 lysis buer (20 mM HEPES, pH 7.5, 150 mM NaCl, 10% glycerol, 1% Nonidet P-40, 100 mM Na 3 VO 4 , 1% aprotinin, 1 mM phenylmethylsulfonyl¯uorid (PMSF), and 10 mg/ml leupeptin) was added and cells lysed for 10 min on ice before transfer to Eppendorf tubes. Cell debris was removed by centrifugation. Supernatants were transferred to new tubes and 0.1 mg of c-Src antibodies (SRC 2; Santa Cruz Biotechnology, Inc., CA, USA) was added. The samples were mixed end-over-end at 48C for 1.5 h before addition of immobilized protein-A (Immunosorb, EC Diagnostics, Uppsala, Sweden) and a ®nal 45 min mixing. The precipitates were washed three times in Nonidet P-40 lysis buer and once in Src kinase buer (20 mM HEPES, pH 7.5, 10 mM MnCl 2 , 0.05% Triton X-100, and 1 mM dithiothreitol (DTT). The beads were resuspended in 40 ml Src kinase buer supplemented with 5 mCi of [g-32 P]ATP (Amersham; speci®c activity 3000 Ci/mmol) and kinase reaction was carried out for 15 min at 308C. In certain indicated experiments the Src family inhibitor PP1 was present at a concentration of 1 mM in the kinase reaction. The kinase reaction was terminated by addition of 40 ml 26SDS ± polyacrylamide gel electrophoresis (PAGE) sample buer, followed by incubation for 4 min at 958C. Samples were subjected to SDS ± PAGE and the gel was ®xed and then incubated in 10% glutaraldehyde for 30 min in order to cross-link proteins to the gel matrix. The gel was then soaked in 1 M KOH at 558C for 45 min, to remove serine-bound phosphate, ®xed again, dried and analysed using a BioImager BAS 2000 (Fuji).
Raf1 kinase assay
Cell lysates were prepared as described for the Src kinase assay, and stimulated with 100 ng/ml FGF-2 for indicated time points. 1 mg aRaf1 (C-12; Santa Cruz Biotechnology, Inc., CA, USA) was added to the cleared lysates and samples FGFR-1 mediated endothelial cell differentiation P Klint et al were mixed end-over-end 1 h before addition of immobilized protein-A and an additional 45-min mixing. The samples were washed three times in Nonidet P-40 lysis buer and once in Raf1 kinase buer (20 mM Tris, pH 7.5, 10 mM MgCl 2 , 10 mM MnCl 2 , and 1 mM DTT). The beads were resuspended in 40 ml Raf1 kinase buer supplemented with 5 mCi of [g-32 P]ATP and 0.4 mg kinase-inactive MEK (Upstate Biotechnology, Inc., NY, USA) and incubated for 15 min at 308C. The kinase reaction was terminated by addition of 40 ml 26SDS ± PAGE sample buer, followed by incubation for 4 min at 958C. Samples were separated by SDS ± PAGE and the subsequently dried gel was analysed using a Bio-Imager BAS 2000.
MAPK-assay
IBEC were inoculated onto ®bronectin-or collagen-gelcoated dishes (or kept in suspension), stimulated with ligand and washed as indicated above. In experiments using the MEK inhibitor PD98059, the drug was added 1 h prior to addition of FGF-2 and used at a ®nal concentration of 30 mM. 0.5 ml MAPK lysis buer (1% Triton-X 100, 0.5% sodium deoxycholate, 20 mM HEPES, pH 8.0, 10 mM ethylene glycol-bis(b-aminoethyl ether) N,N,N',N'-tetraacetic acid, 5 mM MgCl 2 , 10 mg/ml leupeptin, 1% aprotinin, 1 mM PMSF, 20 mM Na 4 P 2 O 7 , 50 mM NaF, and 100 mM Na 3 VO 4 ) was added and cell lysates were cleared before addition of 5 ml rabbit antiserum against ERK2 (a kind gift of Dr L RoÈ nnstrand, Ludwig Institute for Cancer Research, Uppsala, Sweden) and incubation for 2 h. Immobilized protein-A was included during the last 30 min. Samples were washed twice in MAPK lysis buer, twice in Nonidet P-40 lysis buer and ®nally twice in MAPK kinase buer (20 mM HEPES, pH 8.0, 20 mM MgCl 2 , 2 mM MnCl 2 , and 1 mM DTT). Kinase reaction was in 40 ml MAPK kinase buer supplemented with 10 mg myelin basic protein (MBP; Sigma) and 5 mCi of [g-32 P]ATP and samples were incubated for 15 min at 308C. 26SDS ± PAGE sample buer was added and samples were boiled for 4 min before beeing subjected to SDS ± PAGE and analysis using a Bio-Imager BAS 2000.
Precipitation/immunoprecipitation and immunoblotting IBEC were seeded out onto ®bronectin-or collagen-gelcoated 10 cm dishes and treated as indicated above before lysis in 1 ml Nonidet P-40 lysis buer. Clari®ed lysates were incubated with puri®ed immobilized glutathione S-transferase (GST) ± Grb2 SH2 (a kind gift of Dr J Schlessinger, New York University Medical Center, New York, USA; 50 ml bead volume with 50 mg bound fusion protein) for 2 h endover-end at 48C. Alternatively, PLC-g antiserum (Upstate Biotechnology, Inc., NY, USA) or FAK antibody (F15020; Transduction Laboratories, Inc., Lexington, KY, USA) was added to the clari®ed lysates and after 2 h incubation, immobilized protein-A was added and incubation proceeded for additionally 45 min. The precipitates were washed three times in lysis buer and once in H 2 O. Samples were subjected to SDS ± PAGE before electroblotting to Hybond-C extra membranes (Amersham). The following reagents were used for immunoblotting: anti-phosphotyrosine monoclonal antibody 4G10 (Upstate Biotechnology, Inc., NY, USA), antiserum against Src family members (a kind gift of Dr Roya Hooshmand-Rad, Ludwig Institute for Cancer Research, Uppsala, Sweden), antiserum against Shc and FAK (S14630 and F15020, respectively; Transduction Laboratories, Inc., Lexington, KY, USA), antiserum against Raf1 (C-12; Santa Cruz Biotechnology, Inc., CA, USA) or against PLC-g (Upstate Biotechnology, Inc., NY, USA). Subsequent visualization of proteins on the ®lters was performed using a home-made chemiluminescent cocktail based on a protocol described by Matthews et al. (1985) .
